Everest Medicines Limited (1952.HK)
HKD 47.1
(1.07%)
HKD 47.1
(1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 125.93 Million | 12.79 Million | 54 Thousand | - | - | - |
| Cost of Revenue | 34.41 Million | 4.64 Million | 23 Thousand | - | - | - |
| Gross Profit | 91.51 Million | 8.14 Million | 31 Thousand | - | - | - |
| Operating Expenses | 1.02 Billion | 1.4 Billion | 1.04 Billion | 687.4 Million | 198.52 Million | 126.99 Million |
| Selling, General and Administrative Expenses | 396.57 Million | 603.23 Million | 440.82 Million | 311.07 Million | 34.05 Million | 26.55 Million |
| Research and Development Expenses | 540.05 Million | 809.73 Million | 613.43 Million | 377.41 Million | 150.88 Million | 55.91 Million |
| Other Expenses | 87.62 Million | -4.62 Million | -4.95 Million | -1.08 Million | 13.58 Million | -863.21 Million |
| Cost and Expenses | 1.05 Billion | 1.41 Billion | 1.04 Billion | 687.4 Million | 198.52 Million | 126.99 Million |
| Operating Income | -932.73 Million | -1.4 Billion | -1.04 Billion | -688.45 Million | -176.11 Million | -127.18 Million |
| Interest Expense | 23.05 Million | 5.59 Million | 4.81 Million | 23.82 Million | 2 Million | 1.34 Million |
| Income Tax Expense | - | 8000.00 | 4.81 Million | 23.82 Million | -21.04 Million | -863.32 Million |
| Earnings before Tax | -844.46 Million | -247.27 Million | -1 Billion | -5.65 Billion | -214.51 Million | -991.67 Million |
| Net Income | -844.46 Million | -247.28 Million | -1.01 Billion | -5.68 Billion | -193.47 Million | -991.67 Million |
| Earnings Per Share Basic | -2.70 | -0.83 | -3.46 | -26.46 | -0.68 | -3.50 |
| Earnings Per Share Diluted | -2.70 | -0.83 | -3.46 | -26.46 | -0.68 | -3.50 |
| Weighted Average Shares Outstanding | 313.06 Million | 297.63 Million | 293.23 Million | 214.75 Million | 283.69 Million | 283.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 313.06 Million | 297.63 Million | 293.27 Million | 214.75 Million | 283.69 Million | 283.69 Million |
| Gross Margin | 0.73 | 0.64 | 0.57 | - | - | - |
| EBIT Margin | -5.91 | -115.59 | -18.01 Thousand | - | - | - |
| Profit Margin | -6.71 | -19.33 | -18.76 Thousand | - | - | - |
| EBITDA | -744.62 Million | -198.91 Million | -972.77 Million | -683.02 Million | -195.72 Million | -126.37 Million |
| Earnings Before Tax Margin | -7.41 | -109.46 | -19.43 Thousand | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 150.75 Million | 150.75 Million | 125.93 Million | 58.51 Million | 58.51 Million | 4.44 Million |
| Cost of Revenue | 35.21 Million | 35.21 Million | 34.41 Million | 15.54 Million | 15.54 Million | 1.65 Million |
| Gross Profit | 115.53 Million | 115.53 Million | 91.51 Million | 42.97 Million | 42.97 Million | 2.78 Million |
| Operating Expenses | 451.41 Million | 451.41 Million | 923.45 Million | 269.87 Million | 271.1 Million | 239.19 Million |
| Selling, General and Administrative Expenses | 143.69 Million | 143.69 Million | - | 124.65 Million | 124.65 Million | 73.63 Million |
| Research and Development Expenses | 126.57 Million | 126.57 Million | - | 125.78 Million | 125.78 Million | 144.24 Million |
| Other Expenses | 181.14 Million | 181.14 Million | -19.33 Million | 19.43 Million | - | - |
| Cost and Expenses | 486.63 Million | 486.63 Million | 957.86 Million | 285.42 Million | 286.65 Million | 240.85 Million |
| Operating Income | -335.87 Million | -335.87 Million | -932.73 Million | -226.9 Million | -211.73 Million | -213.89 Million |
| Interest Expense | - | - | 23.05 Million | - | - | 17.08 Million |
| Income Tax Expense | - | - | 79.59 Million | 15.17 Million | - | -2.00 |
| Earnings before Tax | -316.2 Million | -316.2 Million | -844.46 Million | -210.42 Million | -210.42 Million | -211.8 Million |
| Net Income | -316.2 Million | -316.2 Million | -844.46 Million | -210.42 Million | -210.42 Million | -211.8 Million |
| Earnings Per Share Basic | -0.98 | -0.98 | - | -0.65 | -0.65 | -0.70 |
| Earnings Per Share Diluted | -0.98 | -0.98 | - | -0.65 | -0.65 | -0.70 |
| Weighted Average Shares Outstanding | 322.88 Million | 322.88 Million | 313.06 Million | 322.88 Million | 322.88 Million | 302.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 324.11 Million | 324.11 Million | 313.06 Million | 324.11 Million | 324.11 Million | 302 Million |
| Gross Margin | 0.77 | 0.77 | 0.73 | 0.73 | 0.73 | 0.63 |
| EBIT Margin | -2.15 | -2.15 | - | -3.40 | -3.40 | -45.79 |
| Profit Margin | -2.10 | -2.10 | -6.71 | -3.60 | -3.60 | -47.62 |
| EBITDA | -324.27 Million | -324.27 Million | - | -198.78 Million | -198.78 Million | -203.63 Million |
| Earnings Before Tax Margin | -2.23 | -2.23 | -7.41 | -3.88 | -3.62 | -48.09 |
CAST
BRIL
LKMNF
DEDI
CMTNF
IDHC